当前位置: 首页 > 期刊 > 《中国医学创新》 > 2015年第5期
编号:12619870
使用智能肱动脉血压计管理高血压的临床尝试(1)
http://www.100md.com 2015年2月15日 中国医学创新 2015年第5期
     【摘要】 目的:将高血压问题从流体力学的角度阐述,体现个性化,实现“高血压”的个性化治疗。方法:笔者设计了一款智能肱动脉血压计,该仪器具备实时检测、记录和分析患者收缩压、舒张压、脉压差、血压波动的情况,并且具备数据储存功能,可以保存长达6个月的数据。对入组的103例高血压患者,佩戴仪器,将103例患者随机分为三组。第一组34例患者在常规药物治疗基础上仅做数据记录和分析作为常规治疗组;第二组34例患者根据实时数据,仅做药物调整作为药物调整对照组;第三组35例患者在第二组的治疗基础上,增加健康教育和生活方式指导,测试持续6个月作为综合管理对照组。测试结束后,将记录数据进行统计分析。结果:三组患者血压控制情况及控制率比较,差异有统计学意义(P<0.05)。结论:个性化治疗高血压可有效改善血压控制情况。

    【关键词】 个性化治疗; 高血压; 智能肱动脉血压计

    【Abstract】 Objective: To elaborate the high blood pressure from fluid mechanics,reflect the individuality,and achieve “high blood pressure” personalized therapy.Method:The smart brachial artery blood pressure were designed by us with real-time detection, recorded and analysed of systolic blood pressure in patients with diastolic blood pressure, pulse pressure, blood pressure fluctuations, and had the data storage function, which could save up to six months data. The 103 patients were randomly divided into three groups.The first group of 34 patients were treated by conventional drug based on only the data recording and analysis as the conventional treatment group; the second group of 34 patients according to real-time data, were treated only medication adjustment as the medication adjustment control group; the third group of 34 patients therapy on the basis of the second group, were treated by increased health education and lifestyle guidance during six months as the integrated management control group. After the test was completed,the data for statistical analysis was recorded by us. Result: Compared the three groups patients of control blood pressure and control rate,the differences were statistically significant(P<0.05). Conclusion: Personalized treatment of hypertension can improve blood pressure control.
, http://www.100md.com
    【Key words】 Personalized treatment; Hypertension; Smart brachial artery blood pressure

    高血压是以体循环动脉血压持续升高,成人收缩压高于18.6 kPa(140 mm Hg)和/或舒张压高于12 kPa(90 mm Hg)为主要表现的疾病。高血压病治疗方案因年龄、性别、体重、血压值、既往病史、合并症、血生化变化及患者经济承受能力等,治疗个体差异很大。目前,我国高血压患者的自我管理能力较低,缺乏系统监测,治疗以药物为主,总体控制情况有待提高[1-2]。笔者通过长期的临床实践发现,为患者制定个性化的治疗方案,动态监测血压,及时调整降压药物,指导调整生活方式,增加治疗依从性可有效提高高血压的控制率。

    1 资料与方法

    1.1 一般资料 选取2012-2014年就诊本院心内科门诊及住院高血压病患者103例,其中男54例,女49例,年龄36~80岁,平均(64.3±7.8)岁。入选患者纳入标准:(1)符合《中国高血压防治指南(2005年修订版)》中规定的高血压诊断标准;(2)年龄在35~80岁;(3)有明确高血压史,曾经或正在服用抗高血压药患者;(4)无其他心脑血管疾病。排除标准:(1)合并脑血管、肺、肝、肾及造血系统等严重原发性疾病者;(2)精神病患者及无法沟通患者;(3)妊娠。将103例患者随机分为常规治疗组34例、药物调整对照组34例和综合管理对照组35例,其中常规治疗组男17例,女17例,年龄(60.1±9.7)岁;药物调整对照组男18例,女16例,年龄(58.3±10.6)岁;综合管理对照组男18例,女17例,年龄(60.5±8.9)岁,三组患者性别、年龄、治疗前平均血压比较差异无统计学意义(P>0.05),具有可比性。, 百拇医药(范丽丽等)
1 2 3下一页